Clinical Trials Directory

Trials / Completed

CompletedNCT01315665

Effect of Sulforaphane in Broccoli Sprouts on Nrf2 Activation

Evaluation of the Effect of Sulforaphane in Broccoli Sprouts on Nrf2 Activation, Measures of Oxidative Stress, and Neutrophil Migration to Mucosal Surfaces in Healthy and CF Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
University Hospitals Cleveland Medical Center · Academic / Other
Sex
All
Age
18 Years – 49 Years
Healthy volunteers
Accepted

Summary

The purpose of this study to investigate the effect of sulforaphane from macerated broccoli sprouts in humans and to evaluate less invasive methods of assessing potential anti-inflammatory drugs in CF.

Detailed description

The hypothesis to be tested is that sulforaphane consumed from macerated broccoli sprouts will activate Nrf2, reduce oxidative metabolites and reduce neutrophils in the oral mucosa after 5 days of therapy in healthy volunteers and CF subjects. The study requires 6 brief outpatient visits over 8 days. Study procedures include medical history, height, weight, vital signs, blood and urine collection, nasal curettage, saline mouthwash, and ingestion of broccoli sprouts (100 gm of 3 to 5 day old raw broccoli sprouts once daily for 5 consecutive days).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBroccoli sproutsSubjects (both healthy volunteers and subjects with cystic fibrosis) will consume 100 gm of raw broccoli sprouts once daily for 5 consecutive days.

Timeline

Start date
2011-04-01
Primary completion
2013-02-01
Completion
2013-02-01
First posted
2011-03-15
Last updated
2019-02-15
Results posted
2017-02-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01315665. Inclusion in this directory is not an endorsement.